The Role of Platelets in Cancer Pathophysiology: Focus on Malignant Glioma
AbstractThe link between thrombocytosis and malignancy has been well known for many years and its associations with worse outcomes have been reported mainly for solid tumors. Besides measuring platelet count, it has become popular to assess platelet function in the context of malignant diseases during the last decade. Malignant gliomas differ tremendously from malignancies outside the central nervous system because they virtually never form distant metastases. This review summarizes the current understanding of the platelet–immune cell communication and its potential role in glioma resistance and progression. Particularly, we focus on platelet-derived proinflammatory modulators, such as sphingosine-1-phosphate (S1P). The multifaceted interaction with immune cells puts the platelet into an interesting perspective regarding the recent advances in immunotherapeutic approaches in malignant glioma. View Full-Text
Share & Cite This Article
Marx, S.; Xiao, Y.; Baschin, M.; Splittstöhser, M.; Altmann, R.; Moritz, E.; Jedlitschky, G.; Bien-Möller, S.; Schroeder, H.W.; Rauch, B.H. The Role of Platelets in Cancer Pathophysiology: Focus on Malignant Glioma. Cancers 2019, 11, 569.
Marx S, Xiao Y, Baschin M, Splittstöhser M, Altmann R, Moritz E, Jedlitschky G, Bien-Möller S, Schroeder HW, Rauch BH. The Role of Platelets in Cancer Pathophysiology: Focus on Malignant Glioma. Cancers. 2019; 11(4):569.Chicago/Turabian Style
Marx, Sascha; Xiao, Yong; Baschin, Marcel; Splittstöhser, Maximilian; Altmann, Robert; Moritz, Eileen; Jedlitschky, Gabriele; Bien-Möller, Sandra; Schroeder, Henry W.; Rauch, Bernhard H. 2019. "The Role of Platelets in Cancer Pathophysiology: Focus on Malignant Glioma." Cancers 11, no. 4: 569.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.